|
|||||
Researchers in Australia are conducting clinical trials of blood tests among cancer patients to help determine the course of their treatment, including the need for chemotherapy. . . . → Read More: Trials Evaluating Blood Tests to Guide Cancer Treatment 
A cloud-based open-source genomic sequencing program is underway to identify the source and nature of infectious diseases anywhere in the world. . . . → Read More: Infectious Disease Sequencing Service, Training Launched 
Research with lab mice shows prenatal genome editing with techniques including Crispr can correct an inherited defect associated with a fatal congenital liver disorder. . . . → Read More: Prenatal Genome Edits Prevent Inherited Liver Disorder  Comments are closed  New products  biomedical, biotechnology, genomics, life sciences, pharmaceuticals, preclinical, university 
A biotechnology company developing therapies that silence the actions of disease-causing genes is licensing its treatment program for hepatitis-B to Janssen Pharmaceuticals. . . . → Read More: Biotech in $3.7B Licensing Deal for Hepatitis-B One comment - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, clinical trials, equity, genomics, investment, licensing, life sciences, pharmaceuticals While so many of us are able to send away for one of those home testing kits to find out our ancestry, not to mention if we have a predilection towards certain diseases, are these kits valid at all? . . . → Read More: DNA Home Testing — Is It Worth It? 
Mayo Clinic and the company Helix Opco are providing a genomic analysis service for Mayo Clinic patients seeking more detailed insights into their genetic make-up and health outlook. . . . → Read More: Mayo Clinic, Helix Partner on Genomic Analysis One comment - (Comments are closed) Joint ventures/collaborations biomedical, genomics, life sciences, medical device 
The groundcherry, a wild tomato plant that its devotees say has a delicious and unusual flavor, could be grown on farms for sale to consumers thanks to a genome editing project at two New York research institutes. . . . → Read More: Genome Editing Offers Marketable Wild Tomato 
(Marco Verch, Flickr) 1 Oct. 2018. The Food and Drug Administration on Friday authorized for marketing in the U.S. a system for high-speed analysis of bone marrow samples to find low levels of residual cancer cells. The agency’s announcement cleared the ClonoSeq assay developed by Adaptive Biotechnologies in Seattle to test for minimal residual . . . → Read More: FDA Clears Genomic Bone Marrow Test for Low-Level Cancer One comment - (Comments are closed) Regulations biomedical, cancer, clinical trials, engineering, FDA, genomics, life sciences, medical device 
Three medical research centers in the U.S. will begin analyzing the DNA in specimen samples from participants in a large-scale precision medicine initiative conducted by National Institutes of Health. . . . → Read More: Genome Centers Named for Precision Medicine Program One comment - (Comments are closed) Finance, New products biomedical, cancer, clinical trials, genomics, grant, life sciences, NIH, university 
An academic-business team is developing a synthetic antibody to prevent gluten found in some grains from affecting the intestines of people with celiac disease, an intolerance of gluten. . . . → Read More: Synthetic Antibody Neutralizing Gluten in Development One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, chemistry, engineering, Europe, genomics, life sciences, manufacturing, pharmaceuticals, physical sciences, university |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
